January 25, 2018 / 9:23 AM / a month ago

BRIEF-Mithra Pharmaceuticals Announces Last Subject Completes Donesta Phase II Study​

Jan 25 (Reuters) - MITHRA PHARMACEUTICALS SA:

* ‍MITHRA ANNOUNCES LAST SUBJECT COMPLETES DONESTA® PHASE II STUDY​

* ‍PHASE II STUDY ON TRACK TO YIELD TOP LINE DATA LATE Q1 2018​

* ‍260 WOMEN RECRUITED, OVER 200 COMPLETED AT LEAST 12 WEEKS OF TREATMENT IN PHASE II STUDY​

* ‍12-WEEK DATA GENERATED FOR ADDITIONAL 15% OF SUBJECTS TO IMPROVE ROBUSTNESS OF ANALYSIS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below